“Effect of local application of simvastatin in bone regeneration of peri-apical defects-a clinico-radiographic study
ConclusionIntragroup analysis of CBCT- Periapical Index (PAI) scores at 6th and 12th month revealed a significant change in the SIM group (p = 0.018 and 0.001 respectively), compared to PRF (p = 0.026 and 0.001 respectively) and HA (p = 0.053 and 0.039 respectively). Intergroup analysis of change in the level of CBCT-PAI score was highly significant (p = 0.003).SIM caused a more considerable change in the level of CBCT-PAI score compared to other groups, thereby indicating a faster rate of bone regeneration. (Source: Dental Technology Blog)
Source: Dental Technology Blog - September 19, 2020 Category: Dentistry Source Type: news
Mislabeled Clopidogrel Lot Recalled, May Contain Simvastatin Mislabeled Clopidogrel Lot Recalled, May Contain Simvastatin
International Laboratories has recalled one lot of clopidogrel tablets packaged in bottles of 30 tablets because it may contain simvastatin instead of clopidogrel.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2020 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
In this interview with Dr. Lee Hooper we find out more about this new Cochrane review -Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseTell us about this Cochrane ReviewThere is a great deal of public belief in the cardiovascular benefits of omega-3 fats. Intakes of long-chain omega-3 fats in the US are higher from dietary supplements than foods. But public health advice differs across countries. The National Institute for Health and Clinical Excellence in the UK encourages people to eat oily fish intake (the major source of long-chain omega-3 f ats) but discourages supplementatio...
Source: Cochrane News and Events - February 5, 2020 Category: Information Technology Authors: Katie Abbotts Source Type: news
Statins Tied to Risk of Skin Infections
People taking statins to lower cholesterol were at increased risk of developing staph skin infections. (Source: NYT Health)
Source: NYT Health - November 4, 2019 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Cholesterol Statins (Cholesterol-Lowering Drugs) Diabetes Drugs (Pharmaceuticals) Zocor (Drug) Skin Infections Staphylococcus Aureus Source Type: news
High-Intensity Lipid Lowering May Aid Very Elderly After ACS
TUESDAY, Aug. 6, 2019 -- Among patients hospitalized for acute coronary syndrome (ACS), the greatest benefit from simvastatin-ezetimibe compared with simvastatin alone to lower lipid levels was observed in those 75 years of age or older, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 6, 2019 Category: Pharmaceuticals Source Type: news
Model Explores How Statins Alter Multiple Sclerosis Outcomes
FRIDAY, June 7, 2019 -- Simvastatin ' s beneficial effects on clinical outcomes and brain atrophy in patients with multiple sclerosis (MS) are largely independent of cholesterol levels, according to a post hoc study published in the May 28 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2019 Category: Pharmaceuticals Source Type: news
International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets USP, 75 mg packaged in bottles of 30 tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A
International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel tablets USP 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 21, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Lipitor (atorvastatin) vs. Vytorin (simvastatin and ezetimibe)
Title: Lipitor (atorvastatin) vs. Vytorin (simvastatin and ezetimibe)Category: MedicationsCreated: 5/17/2019 12:00:00 AMLast Editorial Review: 5/17/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - May 17, 2019 Category: Cardiology Source Type: news
Statins' potential to treat MS unrelated to lowering cholesterol
(University College London) The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS) -- for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL study has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2019 Category: International Medicine & Public Health Source Type: news
ezetimibe and simvastatin, Vytorin
Title: ezetimibe and simvastatin, VytorinCategory: MedicationsCreated: 1/31/2005 12:00:00 AMLast Editorial Review: 3/14/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - March 14, 2019 Category: Cardiology Source Type: news
Statins May Increase Risk of Diabetes
The risk may be especially high in those who are overweight. (Source: NYT Health)
Source: NYT Health - March 7, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Diabetes Statins (Cholesterol-Lowering Drugs) Obesity Weight Zocor (Drug) Source Type: news
Onset of Musculoskeletal Adverse Events Varies Between Statins
MONDAY, Nov. 19, 2018 -- The onset of musculoskeletal adverse events (MAEs) during statin monotherapy is significantly faster with use of atorvastatin and rosuvastatin versus simvastatin, according to a study published online Nov. 7 in Pharmacology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2018 Category: Pharmaceuticals Source Type: news
